Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

Science Breakthrough of the Year


The most common types of cancer treatment are surgery, chemotherapy, and radiation, but we're well aware of their limitations. So, scientists are continually searching for new therapies.

One that's showing great promise is immunotherapy, a revival of an approach from a century ago. Immunotherapy activates a person's own immune system to fight cancer and there are three main types.

The first uses antibodies which are proteins produced by specialized immune cells. Antibodies recognize and attach to molecules on the surface of cancer cells killing them.

Another uses cytokines which are protein molecules that control the activities of the immune system much like the conductor of a symphony. Cytokines activate a myriad of molecules and cells in the immune system to destroy cancer cells.

Finally, there are cell-based therapies using T cells. Scientists extract these immune cells from tumors, grow them to high numbers in the lab, enhance their cancer killing properties, and reintroduce them into the body.

Lately we've seen remarkable results using cancer immunotherapy on melanoma, an aggressive skin cancer. Researchers recently identified a T cell protein, PD-1, that was inhibiting the cell's cancer killing potential. When they blocked PD-1, patients lived well beyond expected survival times.

In another study, this time with removing T cells from leukemia patients and reengineering them to recognize and target cancer cells, trials have shown 45 of 75 patients went into remission.

Cancer immunotherapy's potential is so promising that in 2013 it was named the 'Breakthrough of the Year'. Let's hope it continues to surprise us.

More Information

Breakthrough of the Year 2013
From the journal Science

Cancer Immunology
From Johns Hopkins Medicine

What Is Cancer Immunotherapy?
Nice infographic about cancer immunotherapy from the Cancer Research Institute


Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.


Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

See all podcasts and radio stations

The web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.